Loading
Latest filing published 10 Dec 2021 for Brainstorm Cell Therapeutics INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Sankesh Abbhi is known so far (10 December 2021): a share grant, in Brainstorm Cell Therapeutics Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration